Sukanya Charuchandra

2 weeks ago | hepmag.com | Sukanya Charuchandra

In a major clinical trial across South Korea and Taiwan, researchers found that starting antiviral therapy for hepatitis B early—before signs of liver damage appear—significantly reduced the risk for liver cancer and other severe complications. These findings, published in The Lancet Gastroenterology & Hepatology, support updated treatment guidelines that primarily focus on viral load, not liver enzyme levels.

3 weeks ago | hepmag.com | Sukanya Charuchandra

For people with liver cirrhosis and recurrent hepatic encephalopathy, fecal microbiota transplantation (FMT) may offer a new line of defense. Researchers found that FMT—delivered by capsule or enema and from either vegan or omnivorous donors—was safe and associated with significantly lower rates of encephalopathy recurrence, according to research published in the Journal of Hepatology. Notably, the benefits were associated with changes in gut bacteria types.

1 month ago | advancedsciencenews.com | Sukanya Charuchandra

Achieving the Paris Agreement’s 1.5 °C climate target may come at an unexpected cost: shrinking croplands. A new study finds global cropland could shrink by nearly 13% under current national climate pledges, with the steepest losses in the Global South. Under the Paris Agreement, countries must adhere to specific climate pledges to mitigate global temperature rise. Even so, keeping warming within 2 °C by 2100 is a long shot.

2 months ago | hepmag.com | Sukanya Charuchandra

Without better detection and effective treatment, the clinical burden of metabolic dysfunction-associated fatty liver disease (MASLD) is expected to rise dramatically over the next 30 years, with cases of decompensated cirrhosis more than tripling, liver cancer nearly doubling and liver transplants increasing almost fourfold. Researchers generated these projections, which were published in JAMA Network Open, using a simulation model.

2 months ago | advancedsciencenews.com | Sukanya Charuchandra

A new study identified the potential pathway responsible for linking high hemoglobin to polycystic ovary syndrome.